Sunesis Pharmaceuticals appoints William Quinn as CFO
Prior to joining Sunesis, Mr. Quinn was President and Chief Executive Officer of Bullet Biotechnology, a company developing immunotherapies for cancer and autoimmune diseases, which he founded in 2011.
From 2003 to 2011, Mr. Quinn held various management positions at Jazz Pharmaceuticals, helping the company grow from a four-person startup to a successful commercial specialty pharmaceutical company.
Mr. Quinn began his career in the life science industry at Novation Biosciences.
He also has prior investing experience from his time as an Associate Partner at Mobius Venture Capital.
Mr. Quinn obtained his MBA from the Stanford Graduate School of Business and also earned an MA and BA from Stanford University.